Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS) (ACCSS)
Primary Purpose
Placenta Accreta
Status
Unknown status
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
ACCSS
Sponsored by
About this trial
This is an interventional treatment trial for Placenta Accreta focused on measuring Peripartum Hystrectomy, Postpartum Haemorrhage
Eligibility Criteria
Inclusion Criteria:
- The women at 32 weeks' gestation with central (anterior dominant, posterior) placenta praevia.
- The women with Placenta Accreta Spectrum disorders having myometrial invasion limited to the uterine serosa (Grade 1, 2, and 3a) without involvement of urinary bladder and other pelvic organs.
- The women wishing to conserve the uterus at the time of caesarean section.
Exclusion Criteria:
- The patients with placenta accreta spectrum disorder with bladder and other organs involvement (Grade 3b, 3c) diagnosed prenatally and during caesarean section.
- The patients with laterally situated right and left placentae.
- The recruited patients who required emergency caesarean section.
Sites / Locations
- Sharif Medical and Dental collegeRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Single Group
Arm Description
A. Chohan Continuous squeezing Suture (ACCSS): An obstetrical procedure using half circle 40mm round body polyglactin 910 suture # 1 (Vicryl plus by Ethicon ®) for control of haemorrhage from the lower segment, in patients with Placenta Accreta for the prevention of hysterectomy at caesarean section
Outcomes
Primary Outcome Measures
Peripartum Hysterectomy
Absolute number of peripartum hysterectomies within the study group
Secondary Outcome Measures
Application time of suture in minutes
Application time of suture plus time to complete haemostasis in minutes
Estimated blood loss
Estimate of blood loss in milliliters (ml) intraoperatively and within first 24 hours
Number of units of blood transfusions
Number of blood transfusions intraoperatively and within first 24 hours
Intensive care unit admissions
Number of days of admission in Intensive care unit
Duration of stay in hospital
Duration of stay in hospital in days
Urinary tract trauma and its complication
Bladder trauma/ vesicovaginal fistula
Uterine complications
Uterine necrosis/abscess formation
Secondary postpartum hemorrhage
Abnormal uterine bleeding within 6 weeks
Maternal mortality
Number of mothers dying in relation to cesarean section within 6 completed weeks
Full Information
NCT ID
NCT05070689
First Posted
September 27, 2021
Last Updated
January 16, 2022
Sponsor
Sharif Medical Research Center
1. Study Identification
Unique Protocol Identification Number
NCT05070689
Brief Title
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
Acronym
ACCSS
Official Title
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS) for Controlling Haemorrahge From Lower Uterine Segment at Caesarean Section
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 15, 2021 (Actual)
Primary Completion Date
April 14, 2022 (Anticipated)
Study Completion Date
May 31, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sharif Medical Research Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Placenta Accreta Spectrum (PAS) disorders are rising in incidence due to increased rate of repeat caesarean sections. Peripartum hysterectomy remains the only definitive treatment of massive postpartum haemorrhage related to this condition. Researchers have described conservative treatments in the form of pelvic devascularization under radiological control, myometrial resection with placenta in situ, and various suturing techniques some involving inversion of cervix. Variable success rates are described, but search continues for a simple, safe and effective treatment. The objective of this study is to assess the simplicity, safety and efficacy of A. Chohan Continuous Squeezing Suture (ACCSS) in the management of PAS.
Detailed Description
Placenta accreta spectrum has opened up a new era in the history of PPH, as forcible separation of adherent placenta leads to massive bleeding from placental bed . Peripartum hysterectomy has emerged as gold standard treatment for this variety of PPH (3 folds rise over uterine atony) with its overall morbidity of 40-50%, and mortality of 7-10% in case of placenta percreta . The fear of placental bed bleeding has led to the development of conservative management like "leaving the placenta in situ approach" with its wide range of mild to severe, and serious morbidities . The conservative surgical techniques (The triple P procedure, one step conservative surgery approach) have also used the concept of non-separation of placenta and have instead adopted resection of myometrium with placenta in situ . These surgeries involve devascularisation of deep pelvic / major abdominal vessels and ligation of complex arterial anastomosis making the procedure technically difficult. Moreover, the devascularisation is done under extensive and expensive interventional radiological equipment which places the procedures out of reach for the routine setups particularly in the under developed countries. Another conservative surgical technique (stepwise surgical approach) , which described separation of placenta also mainly relied upon devascularisation of pelvic organs by bilateral ligation of anterior branch of internal iliac artery rather than elaborating the details of technique of controlling haemorrhage at the actual bleeding site.
Rationale of ACCSS ACCSS is a novel suturing technique addresses the management of placenta praevia and PAS following the orthodox approach of separation of placenta, taking the challenge of controlling massive haemorrhage. The rational of ACCSS is; i. Placental bed is the ultimate area of concern in women with placenta praevia and PAS, and it generally spreads over the whole inner surface of lower uterine segment, but the placental attachment and bleeding area upon its separation does not extend onto the internal os and into the vagina.
ii. Lower uterine segment is thin, flexible, squeezable and holds the suture well.
iii. Internal cervical os is a fixed structure, and has a ring with sufficient strength to function as anchor to the suture.
iv. Taking half thickness of internal cervical os into suture does not alter the anatomy and uterine drainage remains unaffected.
v. Deep pelvic devascularization by ligation or balloon tamponade occlusion (under radiological control) of deep pelvic vessels was not the part of ACCSS procedure. Bilateral uterine artery ligation was added to it because occlusion of the uterine artery or its branches is useful procedure to stop upper uterine bleeding , it does not appear to affect fertility or obstetric outcome and vascular occlusion is only temporary, as recanalization soon ensures normal uterine circulation . The haemostatic effect of ACCSS is therefore independent and does not rely upon supportive measures.
SURGICAL PROCEDURE The caesarean sections in this study will be performed between 37 and 38 weeks of gestation on all patients. Haematology department will be placed on alert with availability of 4 units of cross matched fresh blood and fresh frozen plasma. All surgeries will be performed by principal investigators (Prof Dr. Arshad Chohan & Prof. Dr. Fauzia). A multidisciplinary team comprising of experienced obstetricians, anaesthetist, and paediatrician will be involved during the procedure. Prophylactic antibiotic (ceftriaxone 1gm intravenously) will be administered to all patients before surgery.
At caesarean section Pfannenstiel incision will be used for all patients. After opening the abdomen, a clinical assessment about the depth of invasion of the placenta will be made to exclude the involvement of bladder and other pelvic organs. The features noted at this assessment will be abnormal placental bulge and hypervascularity on uterine serosal surface, and placental invasion into the urinary bladder and/or other pelvic organs. Prior to uterine incision placental site will be gently reconfirmed with the examining hand to ascertain an easy fetal access and to avoid cutting of placenta particularly in case of anterior dominant placenta. A transverse incision will be given in the lower uterine segment (LUS) above the insertion of placenta and the baby will be delivered. At delivery of baby10 iu of oxytocin will be given intravenously, followed by 40 iu in 500 ml of normal saline at the rate of 125ml/hour for first 24 hours as per hospital policy for caesarean section for PAS. The uterus will be exteriorized without making any efforts to remove the placenta. The bleeding edges of the uterine incision will be held with Green-Armitage forceps to minimize bleeding. The visceral peritoneum will be displaced downwards with sharp and blunt dissection to allow suturing on the inner side of the LUS. Bladder will be dissected away only if found adherent with the lower uterine segment from previous caesarean sections. Uterine arteries will be ligated on both sides and any blood vessels on the way will be secured. The placenta will then be removed to as close to complete as possible. The lower uterine segment will be packed with sponge to arrest haemorrhage temporarily while preparing for the suture.
ACCSS Application The packing will be removed and the ring of internal os will be identified with the index and middle finger of one hand and held with Babcock forceps with the other hand. On the exposed inner surface of the LUS, suturing will be started from the left corner of uterine incision, using half circle 40mm round body polyglactin 910 suture # 1 (vicryl plus by Ethicon ®) taking multiple half cm bites through half-thickness of the tissue at half cm intervals to reach the outer half of ring of internal os. The suture will then tied and first knot secured causing squeezing of uterine tissue. From here onwards similar sutures will be placed continuously at 1 cm distance till the right corner will be reached, where the second knot will be secured. During suturing the patency of the internal os will be ensured. The continued pull on the suture is expected to cause squeezing of the LUS and arrest bleeding from all sinuses present at the placental site . A similar suture will be applied on the posterior uterine wall in case of bleeding from posterior uterine wall. The suture will be started from the outer half of the posterior lip of the ring of the internal os and going up to the highest bleeding point on the posterior wall of the uterus, continuing from the left to right end of the uterine incision . Any leftover bleeding points will be secured with separate sutures to ensure complete haemostasis. The uterine incision will be closed in two layers as done in a routine lower segment caesarean section. Any additional medical or surgical therapy instituted will be recorded.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Placenta Accreta
Keywords
Peripartum Hystrectomy, Postpartum Haemorrhage
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Single Group
Arm Type
Experimental
Arm Description
A. Chohan Continuous squeezing Suture (ACCSS): An obstetrical procedure using half circle 40mm round body polyglactin 910 suture # 1 (Vicryl plus by Ethicon ®) for control of haemorrhage from the lower segment, in patients with Placenta Accreta for the prevention of hysterectomy at caesarean section
Intervention Type
Procedure
Intervention Name(s)
ACCSS
Intervention Description
A. Chohan Continuous Squeezing Suture (ACCSS)
Primary Outcome Measure Information:
Title
Peripartum Hysterectomy
Description
Absolute number of peripartum hysterectomies within the study group
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Application time of suture in minutes
Description
Application time of suture plus time to complete haemostasis in minutes
Time Frame
within 20 minutes
Title
Estimated blood loss
Description
Estimate of blood loss in milliliters (ml) intraoperatively and within first 24 hours
Time Frame
First 24 hours
Title
Number of units of blood transfusions
Description
Number of blood transfusions intraoperatively and within first 24 hours
Time Frame
First 24 hours
Title
Intensive care unit admissions
Description
Number of days of admission in Intensive care unit
Time Frame
7 days
Title
Duration of stay in hospital
Description
Duration of stay in hospital in days
Time Frame
7 days
Title
Urinary tract trauma and its complication
Description
Bladder trauma/ vesicovaginal fistula
Time Frame
6 weeks
Title
Uterine complications
Description
Uterine necrosis/abscess formation
Time Frame
6 weeks
Title
Secondary postpartum hemorrhage
Description
Abnormal uterine bleeding within 6 weeks
Time Frame
6 weeks
Title
Maternal mortality
Description
Number of mothers dying in relation to cesarean section within 6 completed weeks
Time Frame
6 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The women at 32 weeks' gestation with central (anterior dominant, posterior) placenta praevia.
The women with Placenta Accreta Spectrum disorders having myometrial invasion limited to the uterine serosa (Grade 1, 2, and 3a) without involvement of urinary bladder and other pelvic organs.
The women wishing to conserve the uterus at the time of caesarean section.
Exclusion Criteria:
The patients with placenta accreta spectrum disorder with bladder and other organs involvement (Grade 3b, 3c) diagnosed prenatally and during caesarean section.
The patients with laterally situated right and left placentae.
The recruited patients who required emergency caesarean section.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Muhammad Arshad Chohan, FRCOG
Phone
+923004027250
Email
marshadchohan@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Fauzia Butt
Phone
+923009427094
Email
drfauziabutt@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Muhammad Arshad Chohan, FRCOG
Organizational Affiliation
Sharif Medical And Dental College
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sharif Medical and Dental college
City
Lahore
State/Province
Pakistan/Punjab
ZIP/Postal Code
54000
Country
Pakistan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Muhammad Arshad Chohan, FCPS, FRCOG
Phone
+923004027250
Email
marshadchohan@hotmail.com
First Name & Middle Initial & Last Name & Degree
Fauzia Butt, FCPS
Phone
+923009427094
Email
drfauziabutt@hotmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27843354
Citation
Ngwenya S. Postpartum hemorrhage: incidence, risk factors, and outcomes in a low-resource setting. Int J Womens Health. 2016 Nov 2;8:647-650. doi: 10.2147/IJWH.S119232. eCollection 2016.
Results Reference
result
PubMed Identifier
31722942
Citation
Jauniaux E, Gronbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019 Nov 12;9(11):e031193. doi: 10.1136/bmjopen-2019-031193.
Results Reference
result
PubMed Identifier
31173360
Citation
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019 Jul;146(1):20-24. doi: 10.1002/ijgo.12761.
Results Reference
result
PubMed Identifier
29843627
Citation
Huque S, Roberts I, Fawole B, Chaudhri R, Arulkumaran S, Shakur-Still H. Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial. BMC Pregnancy Childbirth. 2018 May 29;18(1):186. doi: 10.1186/s12884-018-1829-7.
Results Reference
result
PubMed Identifier
31984808
Citation
Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martinez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2022 Jan;35(2):275-282. doi: 10.1080/14767058.2020.1716715. Epub 2020 Jan 26.
Results Reference
result
Learn more about this trial
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
We'll reach out to this number within 24 hrs